NCT07703007

Brief Summary

The purpose of this study is to evaluate the skeletal, dentoalveolar \& soft tissue effects of functional clear aligner therapy in growing patient with Skeletal class III malocclusion. Skeletal class III discrepancy has been a therapeutic challenge due to the fact that its therapeutic management seeks not only the correction of the malocclusion but also the aesthetic component of the patient which is affected according to the severity of the discrepancy. Early diagnosis, planning of adequate therapeutic time and choice of devices to correct malocclusion are the essential keys to successful management of class III in all its forms. Functional appliances are commonly used for the treatment of skeletal class III malocclusion. Removable aesthetic appliance therapy as clear aligner becomes an increasingly common addition to the orthodontic armamentarium. It offers certain advantages over traditional appliance orthodontic treatments; these include fewer clinical emergencies and improved aesthetics, comfort, oral hygiene, periodontal health, and lack of soft tissue irritation. The aim of this study is to evaluate the skeletal, dentoalveolar \& soft tissue effects of functional clear aligner therapy in growing patient with Skeletal class III malocclusion. A total of four blocks are digitally designed, with two blocks placed in the maxillary aligner in the anterior region and two blocks placed in the mandibular aligner in the posterior region. The blocks are designed as inclined planes to guide mandibular repositioning, simulating the reverse twin block mechanism. The upper and lower bite blocks are designed to interact with each other through coherent, specifically designed 70° inclined planes, allowing controlled mandibular repositioning during occlusal contact. Optimized attachments are digitally placed on selected teeth to enhance aligner retention and control tooth movement. Oral Health Related Quality of Life (OHRQoL) assessments will be incorporated as an outcome measure in addressing and measuring clinically meaningful change.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
11mo left

Started Feb 2026

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress33%
Feb 2026Jul 2027

Study Start

First participant enrolled

February 12, 2026

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 4, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 14, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 13, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 13, 2027

Last Updated

July 14, 2026

Status Verified

February 1, 2026

Enrollment Period

1 year

First QC Date

July 4, 2026

Last Update Submit

July 10, 2026

Conditions

Keywords

skeletal class III malocclusionFunctional clear alignerGrowing patientGrowth modification

Outcome Measures

Primary Outcomes (3)

  • Change in skeletal cephalometric measurements

    Anteroposterior and vertical skeletal changes will be assessed using standardized lateral cephalometric radiographs obtained at baseline and at the end of treatment. The evaluated parameters include SNA (°), SNB (°), ANB (°), Wits appraisal (mm), lower anterior facial height (LAFH, mm), upper anterior facial height (UAFH, mm), total anterior facial height (TAFH, mm), posterior facial height (PFH, mm), Frankfort mandibular plane angle (FMA, °), and Y-axis angle (°).

    Baseline and at the end of active treatment.

  • Change in dentoalveolar cephalometric measurements

    Dentoalveolar changes will be assessed using standardized lateral cephalometric radiographs obtained at baseline and at the end of treatment. The evaluated parameters include upper incisor inclination to the SN plane (U1-SN, °), lower incisor inclination to the mandibular plane (IMPA, °), interincisal angle (°), U1-NA (mm and °), and L1-NB (mm and °)

    Baseline and at the end of active treatment.

  • Change in soft tissue cephalometric measurements

    soft tissue changes will be assessed using standardized lateral cephalometric radiographs obtained at baseline and at the end of treatment. The evaluated parameters include upper lip to E-line (UL-E, mm), lower lip to E-line (LL-E, mm), and nasolabial angle (°).

    Baseline and at the end of active treatment.

Secondary Outcomes (1)

  • OHRQoL (Oral Health-related Quality of Life) assessments are being incorporated into clinical studies and trials to measure efficaciousness of treatment with the goal of improving care.

    12 months

Study Arms (1)

Growing patients with mild skeletal class III

EXPERIMENTAL

Functional Clear Aligner

Device: Functional Clear Aligner

Interventions

A customized functional clear aligner appliance designed as a reverse twin block for growing patients with skeletal Class III malocclusion. The appliance incorporates digitally designed anterior maxillary and posterior mandibular bite blocks with 70° inclined planes to guide controlled mandibular repositioning while maintaining the esthetic and functional advantages of clear aligner therapy.

Growing patients with mild skeletal class III

Eligibility Criteria

Age8 Years - 11 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients' age (8-11) years (CVM stages 2-3)
  • Mild class III skeletal pattern (Wits appraisal = 0 to -8)
  • Mild to moderate reverse overjet (-1 to -4)
  • Overbite (1-5)
  • Growing patients
  • Average or below average maxillary-mandibular plane angle and lower facial height
  • Mild incisors compensations

You may not qualify if:

  • Severe class III skeletal pattern
  • Long facial height
  • Bad oral hygiene
  • Systemic condition that may interfere with treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Mansoura University

Al Mansurah, Dakahlia Governorate, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Functional Clear Aligner
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2026

First Posted

July 14, 2026

Study Start

February 12, 2026

Primary Completion (Estimated)

February 13, 2027

Study Completion (Estimated)

July 13, 2027

Last Updated

July 14, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

There is no plan to make de-identified individual participant data (IPD) available to other researchers.

Locations